Skip to content

Salvia divinorum: all studies

Page 22 of 41: studies 211 to 220 of 407, newest first. Back to the salvia divinorum overview

Research

The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.

Neuropharmacology September 1, 2007 Catherine B Willmore-Fordham, Daniel M Krall, Christopher R Mccurdy et al. 49 citations

Data from clinical and preclinical studies converge implicating the plant-derived hallucinogen salvinorin A as an important pharmacologic tool; this psychoactive compound may expand scientific understandings on mammalian kappa-opioid receptor systems. Human salvinorin A effects, consistent with kappa-opioid receptor agonism, include antinociception, sedation, dysphoria and distorted...

DOI: 10.1016/j.neuropharm.2007.06.008 (opens in new tab) Full text (opens in new tab) Neuroscience: brain chemistry Brain receptors Perception Mood regulation +5

Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.

Planta Medica August 1, 2007 Oliver Grundmann, Stephen M Phipps, Immo Zadezensky et al. 81 citations

Salvia divinorum L. (Lamiaceae) has been used for centuries by the Mazatecan culture and has gained popularity as a recreational drug in recent years. Its potent hallucinogenic effects seen in case reports has triggered research and led to the discovery of the first highly selective non-nitrogenous kappa opioid receptor agonist salvinorin A. This review critically evaluates the reported...

DOI: 10.1055/s-2007-981566 (opens in new tab) Full text (opens in new tab) Salvinorin a Salvia divinorum extract Natural compound Plant-derived compound +17

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.

Journal of Medicinal Chemistry July 26, 2007 Denise S Simpson, Peter L Katavic, Anthony Lozama et al.

Further modification of salvinorin A (1a), the major active component of Salvia divinorum, has resulted in the synthesis of novel neoclerodane diterpenes with opioid receptor affinity and activity. We report in this study that oxadiazole 11a and salvidivin A (12a), a photooxygenation product of 1a, have been identified as the first neoclerodane diterpenes with kappa antagonist activity. This...

Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway.

Phytochemistry July 1, 2007 Lukasz Kutrzeba, Franck E Dayan, J'Lynn Howell et al. 45 citations

Salvinorin A, a neoclerodane diterpenoid, isolated from the Mexican hallucinogenic plant Salvia divinorum, is a potent kappa-opioid receptor agonist. Its biosynthetic route was studied by NMR and HR-ESI-MS analysis of the products of the incorporation of [1-(13)C]-glucose, [Me-(13)C]-methionine, and [1-(13)C;3,4-(2)H2]-1-deoxy-D-xylulose into its structure. While the use of cuttings and...

Subjective effects of Salvia divinorum.

Journal of Psychoactive Drugs June 1, 2007 Phil Dalgarno 21 citations

Salvia divinorum is a hallucinogenic plant native to Mexico, where the Mazatec Indians use it in divinatory rituals as a facilitator for contacting the spirits of the dead. A number of traditions surrounding the ritualistic use of Salvia are still observed. Generally the leaves are chewed for the visionary effects. Salvia has recently been embraced by Western drug cultures, where the...

Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.

Bioorganic & Medicinal Chemistry Letters April 15, 2007 Ruslan V Bikbulatov, Feng Yan, Bryan L. Roth et al.

To study drug-receptor interactions, new thio-derivatives of salvinorin A, an extremely potent natural kappa-opioid receptor (KOR) agonist, were synthesized. Obtained compounds were examined for receptor binding affinity. Analogs with the same configuration at carbon atom C-2 as in natural salvinorin A showed higher affinity to KOR than their corresponding epimers.

Unambiguous NMR spectral assignments of salvinorin A.

Magnetic resonance in chemistry : MRC April 1, 2007 José-luis Giner, David J Kiemle, Lukasz Kutrzeba et al. 14 citations

The complete assignments of the (1)H and (13)C NMR spectra of the hallucinogenic neoclerodane diterpenoid salvinorin A were determined in three different NMR solvents using HSQC, HMBC and COSY. Solvent systems are described that allow the resolution of all (1)H signals. Virtual coupling was observed for the protons at C-2, C-3 and C-4 in the 600 MHz (1)H spectrum in CDCl(3). The complete...

DOI: 10.1002/mrc.1972 (opens in new tab) Full text (opens in new tab) Salvinorin a Structural elucidation Structure determination Molecular structure +11

Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.

Psychopharmacology March 2007 Daniela Braida, Valeria Limonta, Simona Pegorini et al.

The hallucinatory effect and potential abuse of salvinorin A, the major ingredient of Salvia divinorum, has not been documented in animals. The effects of salvinorin A on the zebrafish (Danio rerio) model, through its swimming behavior and conditioned place preference (CPP) task, was studied. Swimming activity was determined in a squared observational chamber after an i.m. treatment of...

Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptor.

Journal of Biological Chemistry February 2, 2007 Timothy A Vortherms, Philip D Mosier, Richard B Westkaemper et al. 40 citations

Salvinorin A, the active component of the hallucinogenic sage Salvia divinorum, is an apparently selective and highly potent kappa-opioid receptor (KOR) agonist. Salvinorin A is unique among ligands for peptidergic G protein-coupled receptors in being nonnitrogenous and lipid-like in character. To examine the molecular basis for the subtype-selective binding of salvinorin A, we utilized an...

DOI: 10.1074/jbc.M609264200 (opens in new tab) Full text (opens in new tab) Drug selectivity Mechanism of action Pharmacology Ligand binding +19